Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Video: Dissecting 2016 NDI Draft Guidance

<p>In this seven-minute video, leaders of the U.S. dietary supplement industry weigh in on the&nbsp;pros and cons of an important guidance document that was&nbsp;published in 2016 by FDA, while <strong>INSIDER</strong> takes a look back at the reaction from a powerful U.S. senator to the previous draft. </p>

In August, FDA issued a 102-page document for the nearly US$40 billion dietary supplement industry. The draft guidance governs the industry’s obligation under federal law to notify FDA before marketing a new dietary ingredient, or NDI, and provide safety-related evidence.

In this seven-minute feature video, INSIDER highlights:

-- the criticism that was unleashed by Sen. Orrin Hatch (R-Utah) and the supplement industry after FDA published the 2011 draft NDI guidance;

-- the pros and cons of the 2016 draft from the perspective of industry leaders; and

-- the relationship between the 102-page document and the NDI notification requirements under the law.

TAGS: Archive
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.